We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
228 hedge funds and large institutions have $1.06B invested in Fate Therapeutics in 2022 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 98 increasing their positions, 59 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
66% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 59
9% more call options, than puts
Call options by funds: $998K | Put options by funds: $916K
3.88% less ownership
Funds ownership: 112.63% → 108.75% (-3.9%)
5% less funds holding
Funds holding: 239 → 228 (-11)
19% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 43
57% less capital invested
Capital invested by funds: $2.45B → $1.06B (-$1.39B)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
228
Holders Change
-11
Holders Change %
-4.6%
% of All Funds
3.67%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
35
Increased
98
Reduced
59
Closed
43
Calls
$998K
Puts
$916K
Net Calls
+$82K
Net Calls Change
-$1.23M
Top Buyers
| 1 |
Millennium Management
New York
|
+$41.8M |
| 2 |
BlackRock
New York
|
+$34M |
| 3 |
State Street
Boston,
Massachusetts
|
+$29.2M |
| 4 |
Two Sigma Investments
New York
|
+$24.7M |
| 5 |
Renaissance Technologies
New York
|
+$23.8M |
